Robert E. Kates - Concepedia

Author

Robert E. Kates

Stanford University

Also Known As

R E Kates, R. E. KATES, R. E. Kates, R.E. Kates, ROBERT E. KATES, Robert E Kates, Robert E. Kates, Robert E. Kates

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Stanford University Stanford Medicine The Ohio State University Korea Association of Teachers of English Harrison Medical Center

About

Robert E. Kates is an author at Stanford University specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	50	2.4K
2	Anesthesia	10	10	652
3	Health Sciences	4	4	176
4	Public Health	4	4	197
5	Natural Sciences	1	1	26

Robert E. Kates

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Tolerance to dobutamine after a 72 hour continuous infusion Donald V. Unverferth, Marvin F. Blanford, Robert E. Kates, The American Journal of Medicine Hour Continuous InfusionPharmacotherapyAnesthesiaMedicinePharmacokinetics	1980	243
Clinical pharmacology of propafenone. Stuart J. Connolly, Robert E. Kates, Cynthia Lebsack, Circulation Heart FailurePropafenone DoseCardiovascular PharmacologyPharmacotherapyExperimental Pharmacology	1983	183
Verapamil disposition kinetics in chronic atrial fibrillation Robert E. Kates, Deborah Keefe, Janice B. Schwartz, Clinical Pharmacology & Therapeutics	1981	118
Dobutamine pharmacokinetics in severe heart failure Robert E. Kates, Carl V. Leier Clinical Pharmacology & Therapeutics Therapeutic Drug MonitoringHeart FailureSevere Heart FailureCardiogenic ShockCardiovascular Disease	1978	102
High-performance liquid chromatographic analysis of verapamil. II. Simultaneous quantitation of verapamil and its active metabolite, norverapamil. Sandra R. Harapat, Robert E. Kates PubMed BiochemistryMedicineBioanalysisSecondary MetaboliteAnalytical Chemistry	1980	97
High-performance liquid chromatographic analysis of verapamil Sandra R. Harapat, Robert E. Kates Journal of Chromatography B Biomedical Sciences and Applications MedicineAnalytical ChemistryLiquid ChromatographyChromatographic AnalysisPharmacology	1980	93
Verapamil protein binding in patients and in normal subjects Deborah Keefe, Yin‐Gail Yee, Robert E. Kates Clinical Pharmacology & Therapeutics Heart FailurePathologyPharmacotherapyThrombosisRenal Function	1981	92
Effects of encainide and its metabolites on energy requirements for defibrillation. Eric Fain, Paul Dorian, J.–M. Davy, Circulation Electrophysiological EvaluationHeart FailureEnergy RequirementsPercent Successful DefibrillationCardiovascular Disease	1986	91
Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia Stuart J. Connolly, Robert E. Kates, Cynthia Lebsack, The American Journal of Cardiology Cardiogenic ShockCardiovascular DiseaseMedicinePhysiologyCardiovascular Pharmacology	1983	85
Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation. Janice B. Schwartz, Deborah Keefe, Robert E. Kates, Circulation Molecular PharmacologyThrombosisCardiovascular DiseaseMedicinePhysiology	1982	84

Page 1